PubRank

Shinichi Toyooka

Author PubWeight™ 190.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 2009 21.94
2 Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005 13.00
3 Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res 2006 4.72
4 Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res 2005 4.25
5 PIK3CA mutations and copy number gains in human lung cancers. Cancer Res 2008 3.42
6 The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005 3.11
7 Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Proc Natl Acad Sci U S A 2012 2.89
8 Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res 2008 2.71
9 Postoperative perforation in the bronchus intermedius membrane after a primary lung cancer resection. Eur J Cardiothorac Surg 2007 2.66
10 Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One 2009 1.94
11 Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 2006 1.91
12 RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 2004 1.84
13 Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002 1.74
14 Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas. J Natl Cancer Inst 2013 1.65
15 CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure. Chest 2009 1.60
16 Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem 2002 1.55
17 Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res 2013 1.54
18 Suppression of inflammatory cytokines during ex vivo lung perfusion with an adsorbent membrane. Ann Thorac Surg 2010 1.49
19 MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. Int J Cancer 2009 1.48
20 Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int J Cancer 2005 1.45
21 Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002 1.43
22 EGFR mutation and response of lung cancer to gefitinib. N Engl J Med 2005 1.42
23 Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib. Lung Cancer 2007 1.40
24 Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin Cancer Res 2004 1.39
25 Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 2002 1.39
26 Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 2003 1.39
27 Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 2004 1.32
28 Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res 2005 1.31
29 Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol 2008 1.30
30 Retracted DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res 2004 1.26
31 Retracted Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 2005 1.25
32 Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 2003 1.23
33 The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer. Oncogene 2005 1.23
34 Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer 2005 1.21
35 Impact of EGFR mutation analysis in non-small cell lung cancer. Lung Cancer 2008 1.20
36 Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy. Lung Cancer 2012 1.17
37 Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int J Cancer 2007 1.16
38 Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. Int J Cancer 2006 1.15
39 Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res 2002 1.13
40 ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer. Lung Cancer 2007 1.11
41 Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. Ann Thorac Surg 2008 1.09
42 The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer. Int J Cancer 2007 1.09
43 Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol 2007 1.07
44 Concern Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 2002 1.07
45 EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib. Lung Cancer 2007 1.05
46 Clinical significance of epidermal growth factor receptor gene mutations on treatment outcome after first-line cytotoxic chemotherapy in Japanese patients with non-small cell lung cancer. J Thorac Oncol 2007 1.05
47 Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer. Lung Cancer 2006 1.04
48 Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations. J Thorac Oncol 2014 1.04
49 Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 2011 1.03
50 Clinical outcomes of short hook wire and suture marking system in thoracoscopic resection for pulmonary nodules. Eur J Cardiothorac Surg 2009 1.03
51 The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. Breast Cancer Res 2010 1.02
52 Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients. J Thorac Oncol 2008 1.02
53 Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 2011 1.01
54 Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer 2004 1.00
55 Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2011 0.99
56 Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am J Pathol 2002 0.99
57 Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. J Heart Lung Transplant 2008 0.98
58 Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer 2003 0.97
59 Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation. Cancer Sci 2007 0.97
60 Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer. Lung Cancer 2007 0.97
61 Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 2007 0.96
62 Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung. Int J Cancer 2006 0.96
63 The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor. Lung Cancer 2011 0.96
64 Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol Rep 2013 0.96
65 Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene 2002 0.95
66 Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res 2004 0.95
67 Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer. Lung Cancer 2011 0.95
68 Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep 2004 0.95
69 Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases. J Vasc Interv Radiol 2011 0.95
70 Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer. Lung Cancer 2009 0.95
71 CT fluoroscopy-guided cutting needle biopsy of focal pure ground-glass opacity lung lesions: diagnostic yield in 83 lesions. Eur J Radiol 2010 0.93
72 DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers. Oncol Rep 2004 0.93
73 SYT-SSX fusion genes in synovial sarcoma of the thorax. Lung Cancer 2004 0.92
74 Impact of age on epidermal growth factor receptor mutation in lung cancer. Lung Cancer 2012 0.92
75 Promoter methylation downregulates CDX2 expression in colorectal carcinomas. Oncol Rep 2005 0.90
76 Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers. J Cancer Res Clin Oncol 2009 0.90
77 DNA methylation in small lung adenocarcinoma with bronchioloalveolar carcinoma components. Lung Cancer 2009 0.90
78 Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy. Clin Biochem 2008 0.90
79 Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification. Oncol Rep 2012 0.90
80 Role of computed tomography fluoroscopy-guided cutting needle biopsy of lung lesions after transbronchial examination resulting in negative diagnosis. Clin Lung Cancer 2011 0.89
81 Basal segmental auto-transplantation after pneumonectomy for advanced central lung cancer. Eur J Cardiothorac Surg 2012 0.89
82 EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol 2015 0.88
83 Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma. Lung Cancer 2008 0.88
84 Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo. Cancer Lett 2005 0.87
85 Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Int J Cancer 2007 0.87
86 The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer. Oncol Rep 2004 0.87
87 Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol 2010 0.86
88 Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients. Surg Today 2013 0.85
89 Long-term improvement in pulmonary function after living donor lobar lung transplantation. J Heart Lung Transplant 2007 0.84
90 Extracorporeal membrane oxygenation bridging to living-donor lobar lung transplantation. Ann Thorac Surg 2009 0.84
91 Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung. J Thorac Oncol 2008 0.83
92 Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer. Acta Med Okayama 2014 0.83
93 The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma. Lung Cancer 2013 0.83
94 DNA methylation status of REIC/Dkk-3 gene in human malignancies. J Cancer Res Clin Oncol 2012 0.83
95 Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer. Ann Surg Oncol 2012 0.83
96 Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers. Clin Lung Cancer 2012 0.83
97 Primary thymic adenocarcinoma with production of carbohydrate antigen 19-9 and carcinoembryonic antigen. Jpn J Thorac Cardiovasc Surg 2004 0.83
98 Epigenetic inactivation of laminin-5-encoding genes in lung cancers. Clin Cancer Res 2003 0.83
99 Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. J Clin Oncol 2007 0.83
100 The epidermal growth factor receptor D761Y mutation and effect of tyrosine kinase inhibitor. Clin Cancer Res 2007 0.83
101 Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer. Int J Cancer 2004 0.83
102 The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas. Oncol Rep 2008 0.83
103 Bronchial mucoepidermoid carcinoma with recurrent hemoptysis in a pregnant woman: report of a case. Surg Today 2008 0.83
104 Impact of prolonged cold preservation on the graft function and gene expression levels in an experimental lung transplantation model. Surg Today 2012 0.82
105 Spontaneous regression of primary lung cancer arising from an emphysematous bulla. Ann Thorac Cardiovasc Surg 2011 0.82
106 Less frequent promoter hypermethylation of DLC-1 gene in primary breast cancers. Oncol Rep 2004 0.82
107 Impact of HER2 and EGFR gene status on gefitinib-treated patients with nonsmall-cell lung cancer. Int J Cancer 2007 0.82
108 Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience. Acta Med Okayama 2011 0.82
109 Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity. Cardiovasc Intervent Radiol 2014 0.81
110 Preclinical evaluation of microRNA-34b/c delivery for malignant pleural mesothelioma. Acta Med Okayama 2014 0.81
111 MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells. Anticancer Res 2012 0.81
112 Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors. J Vasc Interv Radiol 2012 0.81
113 Use of a vessel sealing system versus conventional electrocautery for lung parenchymal resection: a comparison of the clinicopathological outcomes in porcine lungs. Surg Today 2013 0.81
114 Bronchiolitis obliterans organizing pneumonia after radiofrequency ablation of lung cancer: report of three cases. J Vasc Interv Radiol 2012 0.81
115 Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells. Cancer Sci 2011 0.81
116 Influence of radiofrequency ablation of lung cancer on pulmonary function. Cardiovasc Intervent Radiol 2011 0.81
117 Percutaneous computed tomography-guided lung biopsy and pleural dissemination: an assessment by intraoperative pleural lavage cytology. Cancer 2009 0.81
118 A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery. J Thorac Oncol 2008 0.80
119 Early effects of the ex vivo evaluation system on graft function after swine lung transplantation. Eur J Cardiothorac Surg 2011 0.80
120 Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines. BMC Cancer 2007 0.80
121 Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection. Antivir Ther 2015 0.80
122 Surgical resection of a massive primary mediastinal liposarcoma using clamshell incision combined with lower median sternotomy: report of a case. Ann Thorac Cardiovasc Surg 2013 0.80
123 Current status and potential of living-donor lobar lung transplantation. Front Biosci 2008 0.80
124 Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. Transplantation 2008 0.79
125 Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma. Acta Med Okayama 2011 0.79
126 Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment. Cancer Sci 2009 0.79
127 STAT3 expression in activating EGFR-driven adenocarcinoma of the lung. Lung Cancer 2012 0.79
128 Massive subcutaneous and mediastinal emphysema with little pneumothorax treated by surgery after pulmonary radiofrequency ablation. Cardiovasc Intervent Radiol 2013 0.79
129 Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan. Cancer Sci 2006 0.79
130 [Primary mediastinal lymphoma; a clinicopathologic case series]. Kyobu Geka 2012 0.78
131 A case of delayed massive hemothorax caused by the rupture of a pulmonary artery pseudoaneurysm after radiofrequency ablation of lung tumors. Jpn J Clin Oncol 2012 0.78
132 Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancer. Lung Cancer 2006 0.78
133 Resection of the entire first rib for fibrous dysplasia using a combined posterior-transmanubrial approach. Gen Thorac Cardiovasc Surg 2012 0.78
134 Adjuvant chemotherapy for completely resected non-small-cell lung cancer. Acta Med Okayama 2009 0.78
135 Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP. Oncol Rep 2004 0.78
136 Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer. Acta Med Okayama 2010 0.78
137 Calcineurin inhibitor-related cholestasis complicating lung transplantation. Ann Thorac Surg 2010 0.78
138 DNA methylation in lung cancer. N Engl J Med 2008 0.78
139 Silenced expression of NFKBIA in lung adenocarcinoma patients with a never-smoking history. Acta Med Okayama 2013 0.78
140 Simultaneous Multiple Preoperative Localizations of Small Pulmonary Lesions Using a Short Hook Wire and Suture System. Cardiovasc Intervent Radiol 2014 0.77
141 Current status of postoperative follow-up for lung cancer in Japan: questionnaire survey by the Setouchi Lung Cancer Study Group-A0901. Gen Thorac Cardiovasc Surg 2012 0.77
142 Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis. Cardiovasc Pathol 2013 0.77
143 Ileal perforation induced by acute radiation injury under gefitinib treatment. Int J Clin Oncol 2011 0.77
144 Diaphragmatic hernia after percutaneous radiofrequency ablation of lung tumor. J Vasc Interv Radiol 2011 0.77
145 Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2014 0.77
146 Detection of airway ischaemic damage after lung transplantation by using autofluorescence imaging bronchoscopy. Eur J Cardiothorac Surg 2013 0.77
147 Transfissural route used for preoperative localization of small pulmonary lesions with a short hook wire and suture system. Cardiovasc Intervent Radiol 2014 0.76
148 Thoracoscopic lobectomy as salvage surgery for local recurrence of non-small cell lung cancer after carbon ion radiotherapy in an initially operable patient. Ann Thorac Cardiovasc Surg 2014 0.76
149 The need for an individual approach to lung cancer treatment. PLoS Med 2006 0.75
150 Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies. Oncol Lett 2011 0.75
151 Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection. Interact Cardiovasc Thorac Surg 2012 0.75
152 Dry small pleural dissemination of adenocarcinoma of the lung preoperatively detected by PET/CT: a report of two cases. Acta Med Okayama 2008 0.75
153 The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line. Oncol Rep 2003 0.75
154 Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient. Acta Med Okayama 2016 0.75
155 The allelic distribution of a single nucleotide polymorphism in the PDCD5 gene locus of Japanese non-small cell lung cancer patients. Mol Med Rep 2011 0.75
156 A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival. Am J Gastroenterol 2002 0.75
157 Peculiar mechanisms of graft recovery through anti-inflammatory responses after rat lung transplantation from donation after cardiac death. Transpl Immunol 2011 0.75
158 Retraction: DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res 2012 0.75
159 Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms. Acta Med Okayama 2017 0.75
160 [Cross-sectoral Approach of a Perioperative Management Center for General Thoracic Surgery]. Kyobu Geka 2016 0.75
161 Native lung-sparing lobar transplantation for pulmonary emphysema. J Heart Lung Transplant 2008 0.75
162 Bleeding into a pulmonary cyst caused by pulmonary radiofrequency ablation. J Vasc Interv Radiol 2013 0.75
163 Contralateral pneumothorax in bullous lung after pneumonectomy: report of two cases. Gen Thorac Cardiovasc Surg 2012 0.75
164 Usefulness of Thoracoscopic Debridement for Chronic Empyema after an Extrapleural Pneumonectomy. Acta Med Okayama 2016 0.75
165 Adult mesenchymal hamartoma of the chest wall: report of a case. Ann Thorac Cardiovasc Surg 2013 0.75
166 Study about the Efficacy of Metformin to Immune Function in Cancer Patients. Acta Med Okayama 2016 0.75
167 Reconstruction of Anterior Chest Wall with Polypropylene Mesh: Two Primary Sternal Chondrosarcoma Cases. Acta Med Okayama 2017 0.75
168 [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall]. Kyobu Geka 2014 0.75
169 Elevation of antidonor immunoglobulin M levels precedes acute lung transplant rejection. Ann Thorac Surg 2011 0.75
170 [SIGNIFICANCE OF NONCODING RNA IN SURGERY: NONCODING RNA IN LUNG CANCER]. Nihon Geka Gakkai Zasshi 2015 0.75
171 Living-donor lobar lung transplantation for pulmonary arterial hypertension after failure of epoprostenol therapy. J Am Coll Cardiol 2007 0.75